Receptor for advanced glycation endproducts and atherosclerosis: From basic mechanisms to clinical implications.
about
Do advanced glycation end-products play a role in malaria susceptibility?Myeloid-related protein-8/14 is critical for the biological response to vascular injuryDoes accumulation of advanced glycation end products contribute to the aging phenotype?The Emerging Role of HMGB1 in Neuropathic Pain: A Potential Therapeutic Target for NeuroinflammationAdvanced Glycation End Products: Link between Diet and Ovulatory Dysfunction in PCOS?Advanced glycation end products play adverse proinflammatory activities in osteoporosisStable RAGE-Heparan Sulfate Complexes Are Essential for Signal TransductionAdvanced glycation end-products and their receptor-mediated roles: inflammation and oxidative stress.Estrogen replacement therapy in diabetic ovariectomized female rats potentiates postischemic leukocyte adhesion in cerebral venules via a RAGE-related processLocal non-esterified fatty acids correlate with inflammation in atheroma plaques of patients with type 2 diabetes.Precursor of advanced glycation end products mediates ER-stress-induced caspase-3 activation of human dermal fibroblasts through NAD(P)H oxidase 4Autonomic dysfunction is associated with high mobility group box-1 levels in patients after acute myocardial infarctionSerum carboxymethyl-lysine, a dominant advanced glycation end product, is associated with chronic kidney disease: the Baltimore longitudinal study of aging.Dietary intake of advanced glycation end products did not affect endothelial function and inflammation in healthy adults in a randomized controlled trial.Advanced glycation/glycoxidation endproduct carboxymethyl-lysine and incidence of coronary heart disease and stroke in older adultsGlyco-oxidation and cardiovascular complications in type 2 diabetes: a clinical updatePlacental growth factor, pregnancy-associated plasma protein-A, soluble receptor for advanced glycation end products, extracellular newly identified receptor for receptor for advanced glycation end products binding protein and high mobility group boHMGB1 in health and disease.Endogenous secretory receptor for advanced glycation end products is associated with low serum interleukin-1 receptor antagonist and elevated IL-6 in older community-dwelling adults.Endogenous secretory receptor for advanced glycation end products and chronic kidney disease in the elderly population.Dynamic and extensive metabolic state-dependent regulation of cytokine expression and circulating levelsSoluble receptor for advanced glycation end products in COPD: relationship with emphysema and chronic cor pulmonale: a case-control study.Soluble isoform of the receptor for advanced glycation end products as a biomarker for postoperative respiratory failure after cardiac surgerySerum carboxymethyl-lysine, an advanced glycation end product, is associated with increased aortic pulse wave velocity in adults.Advanced glycation end products and their circulating receptors predict cardiovascular disease mortality in older community-dwelling women.Increased serum myeloid-related protein 8/14 level is associated with atherosclerosis in type 2 diabetic patients.Cardiovascular and inflammatory effects of simvastatin therapy in patients with COPD: a randomized controlled trialDiabetes and cancer: Looking at the multiligand/RAGE axis.Fat mass is inversely associated with serum carboxymethyl-lysine, an advanced glycation end product, in adultsInhibitory activities of selected Kampo formulations on human aldose reductase2245G/A polymorphism of the receptor for advanced glycation end-products (RAGE) gene is associated with diabetic retinopathy in the Malaysian population.Serum carboxymethyl-lysine, an advanced glycation end product, is associated with arterial stiffness in older adults.Influence of Physical Activity Intervention on Circulating Soluble Receptor for Advanced Glycation end Products in Elderly SubjectsSkin autofluorescence is increased in patients with carotid artery stenosis and peripheral artery disease.Heparan sulfate is essential for high mobility group protein 1 (HMGB1) signaling by the receptor for advanced glycation end products (RAGE).Receptor for advanced glycation end products involved in circulating endothelial cells release from human coronary endothelial cells induced by C-reactive protein.Cilostazol attenuates the severity of peripheral arterial occlusive disease in patients with type 2 diabetes: the role of plasma soluble receptor for advanced glycation end-products.Antiaging effect of pine pollen in human diploid fibroblasts and in a mouse model induced by D-galactoseCirculating selenium and carboxymethyl-lysine, an advanced glycation endproduct, are independent predictors of anemia in older community-dwelling adultsShear stress modulates RAGE-mediated inflammation in a model of diabetes-induced metabolic stress.
P2860
Q24471760-4A15E707-B126-430A-A152-F75EEE473827Q24627504-949D3778-6EEE-49B5-907E-8318CD580207Q24632710-31F3EAD2-8173-4DF6-85A7-71FA468EE5A0Q26746458-F680B9BA-93A9-4CEF-B847-BADAA2218CABQ26774333-788D218F-FCC8-45A1-A70A-8D99024B4785Q27024641-432337EC-7550-4171-8FB7-80092AF88252Q27678167-B9CE04C2-053B-4C27-813D-6601E5FE512EQ30426453-A560496F-F083-4530-AB2E-7C4315D29640Q33509786-D05BDDEA-4605-47FA-9E05-A8F612BD1366Q33536636-5063D5EE-470F-42FA-BF15-9DAA859A1A80Q33608632-D2B01724-DA61-4036-A499-DE9F3276C659Q33618292-B169D18D-9700-4085-A978-AF772A9B11A3Q33691339-C400D73A-1CDD-4992-A67B-85B199F2BEEBQ33752140-50D2EC06-8525-4739-BA72-75F733B20195Q34217710-79A9ACAC-57A6-4DD2-9EEB-3BBD62E33AA5Q34286094-487CDDBB-6455-4FBA-A8AE-A826CDA21A5DQ34493096-75BE7879-E33E-45B2-9772-03E87B9F8316Q34622835-70CBDDD2-2E9B-4B85-A176-DF8436E27D8CQ34660313-05F9A7A4-ED28-44A0-BF35-36B73018C8E1Q34724954-C6966A9A-499C-409B-B8E0-6D67BCC0DD1AQ34726647-7F2FF4B2-6874-407C-AFCE-10623726E26BQ34774357-8E9B1201-EA39-4E3A-9F8B-A6A26BF9824CQ34875734-90DE0F9B-E7FE-4E07-919F-C70E8D6B1072Q34885399-358CF1F8-6841-41DC-8E34-4B6E8AB63575Q34981419-BD491EAB-1D4C-49C8-81B2-1D9BF609EA31Q35061053-62AEDAB0-0748-48FF-95BE-28223C82DABBQ35063739-4ADE267D-7FF0-4065-AE24-104F92A17120Q35172873-22113F8D-0786-4A74-A520-BCB700F810EFQ35173430-38A8DD80-ECDA-4E1B-B970-7BBC5F98FA22Q35397913-C52C3A53-FF63-46DF-8E8C-0EB2BC418EB7Q35682226-3A33510F-1912-4CB7-BB57-AC53EF70FBE3Q35690158-25D3B1A8-F06D-48F5-9B3A-E4D3C525A680Q35756983-46087037-ADE2-45CE-BCB6-DA187A0BF2A9Q35783715-23E0AB41-BC2F-44AA-A9F5-490387A86BAFQ35842237-32F4AB5E-DF2D-40BE-84DE-8888DDCD2C4FQ35875904-CE4374A8-14E6-45F9-A574-04EFB38554ECQ35882416-476F7801-3275-4323-9083-4E3FCCA2A68DQ35936749-8095ECC5-0842-4694-A6ED-B1E5C19D173FQ36040868-25556E8F-C21E-4C31-A1A5-AC5D2D3377C1Q36042459-B3484F81-231F-439E-AE83-E047ED706B63
P2860
Receptor for advanced glycation endproducts and atherosclerosis: From basic mechanisms to clinical implications.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Receptor for advanced glycatio ...... isms to clinical implications.
@en
type
label
Receptor for advanced glycatio ...... isms to clinical implications.
@en
prefLabel
Receptor for advanced glycatio ...... isms to clinical implications.
@en
P1433
P1476
Receptor for advanced glycatio ...... nisms to clinical implications
@en
P2093
Giuseppina Basta
P356
10.1016/J.ATHEROSCLEROSIS.2007.07.025
P577
2007-09-10T00:00:00Z